Evidence map›Paper›PMID 42828282›Full record

ArticleiScience2026

Cancer cell-intrinsic rewiring of the colorectal cancer secretome.

Maartje Witsen, Theodoros Foskolos, Jelmer J Dijkstra, Miguel Parra-Martinez, Joyce J I Catsman, Paula T van Royen, Bob J Ignacio, Onno Bleijerveld, Marije C Kuiken, Alex van Vliet and 8 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Maartje WitsenDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Theodoros FoskolosDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Jelmer J DijkstraOncode Institute, Utrecht, the Netherlands.
Miguel Parra-MartinezDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Joyce J I CatsmanDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Paula T van RoyenDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Bob J IgnacioDivision of Synthetic Organic Chemistry, Radboud University, Nijmegen, the Netherlands.
Onno BleijerveldProteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Marije C KuikenDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Alex van VlietDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Kim MonkhorstDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Willemijn S M E TheelenDepartment of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Daniel PeeperDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Joris van de HaarDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Kimberly BongerDivision of Synthetic Organic Chemistry, Radboud University, Nijmegen, the Netherlands.
Michiel VermeulenOncode Institute, Utrecht, the Netherlands.
Emile E VoestDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Krijn K DijkstraDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secreted factors are essential mediators of cellular communication that are exploited by tumors to control their environment and evade immune attack. However, how cancer cells rewire their secretome is unclear due to challenges in reliably profiling cancer cell-specific secreted factors. Here, we apply a click chemistry-based approach to selectively profile the secretome of patient-derived colorectal cancer (CRC) and healthy colon organoids. We observe cancer cell-intrinsic rewiring of the secretome during malignancy, with clear separation between microsatellite stable (MSS) and instable cancers. We then leverage this secretomics dataset to identify secreted factors that mark immune-excluded cancers, revealing NOTUM as a marker of decreased T cell infiltration across four independent datasets. Overall, our study provides an in-depth characterization of the cancer cell-intrinsic secretome of MSS-CRC and nominates NOTUM as a secreted factor marking immune-excluded colorectal cancers. This provides a scalable framework to link cancer cell-derived secreted factors to relevant tumor phenotypes.

Indexed as

CRCimmune evasionNOTUMorganoidssecretome

Identifiers

PMID42828282
PMCPMC13632250

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.